Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

One way to capitalize on the artificial intelligence (AI) industry is to invest in companies that could benefit from the technology, have lost significant market value in recent years, and could ...

Recursion Pharmaceuticals is an AI-focused biotech company looking to revolutionize how we develop drugs. It's arguably long overdue. Despite technological advances, the cost and time required to ...

Integrating humanities into AI development is vital because societal impact is shaped by those who understand meaning, not just builders.

Vint Cerf speaks on stage at The 23rd Annual Webby Awards on May 13, 2019 in New York City. Noam Galai/Getty Images for Webby Awards Vint Cerf retired from Google on July 7 after 21 years as the ...

Recursion Pharmaceuticals' approach to drug discovery could advance the industry. Fiverr is implementing a strategy shift that may help it bounce back from recent headwinds. 10 stocks we like better ...

Burmese pythons in Florida are devouring animals as small as rabbits and as big as deer and alligators. How they do it is ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a fundamentally human skill.

Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

Dr. Grant, a contributing Opinion writer, is an organizational psychologist at the Wharton School of the University of Pennsylvania. Ms. Shandell and Ms. Elliott are Ph.D. candidates there. When the ...